Chemo-embolisation of Multifocal Hepatoma

Professor Michael C. Soulen, MD
Professor of Radiology and Surgery University of Pennsylvania Philadelphia, USA

Patient History

  • 52-year-old male with cirrhosis attributed to past alcohol abuse presented with bleeding varices that were banded.
  • MRI demonstrated two hypervascular masses measuring 5-6cm, one in left lateral segment and the other in left medial segment, surrounded by multiple small satellites.
  • Biopsy revealed moderated differentiated hepatoma.
Bead Block Case 1 fig 1

Left hepatic arteriogram: early phase

Bead Block Case 1 fig 2

Left hepatic arteriogram: late phase

 

Bead Block Case 1 fig 3

Left hepatic arteriogram: during embolisation

Procedure

  • Cobra catheter was advanced into the left hepatic artery and beyond the right gastric artery.
  • A solution of 100mg cisplatin, 50mg doxorubicin, 10mg mitomycin-C dissolved in 10ml of radiographic contrast was emulsified with 10ml of ethiodol.
  • 10-15ml of the resulting emulsion was infused slowly into the left hepatic artery.
  • One syringe of 300-500μm Bead Block™ microspheres was added to the remaining emulsion after expressing the excess saline from the syringe.
  • Careful infusion was continued until near-stasis was achieved.

Outcome

  • Angiography of left and common hepatic arteries showed no residual tumour blush.
  • Follow-up visit one month later showed complete necrosis of both masses with no viable tumour identified.
  • Complete radiographic response of multifocal hepatoma to chemo-embolisation.
Bead Block Case 1 fig 4

Arterial phase: gadolinium enhanced MRI

Bead Block Case 1 fig 5

Arterial phase: one month after chemoembolisation

 

Bead Block Case 1 fig 6

Post-embolisation: left hepatic arteriogram

Bead Block Case 1 fig 7

Post-embolisation: common hepatic arteriogram

Regulatory Notices

Worldwide (excluding USA)

Bead Block™ is CE marked and indicated for the treatment of a variety of hypervascular tumours (including Uterine Fibroids) and arteriovenous malformations (AVMs). Bead Block™ may not be indicated for the treatment of Uterine Fibroids in your country, please check with your local distributor. For full prescribing information please refer to Bead Block instructions for use.

USA

In the USA and Canada, Bead Block™ is indicated for the treatment of hypervascular tumors and arteriovenous malformations (AVMs). For full prescribing information please refer to Bead Block USA Instructions for use.